While genetics alone does not determine medication efficacy, understanding your predisposition profile can provide valuable context for provider discussions about expected response timelines and dose requirements
As the first and only FDA-approved oral GLP-1 RA product, several studies have assessed the cost-effectiveness of semaglutide for treating T2DM in China, but none have compared its oral formulation with other GLP-1 RAs listed in Chinas national medical insurance catalogue ( Oral semaglutide demonstrated inferior cost-effectiveness compared to exenatide (ICER: $88,776.61/QALY), possibly due to the latter being the first GLP-1 RA available in the Chinese market, with a lower annual price than other GLP-1 RAs (i.e., semaglutide, dulaglutide, liraglutide, and lixisenatide)
Both face frequent drug shortages based on high demand and limited supply
Molecular F
A review by the FDA is expected by the end of this year, according to Novo Nordisk
Do B12 injections actually help with weight loss